This work investigates the therapeutic potential of an oxygen metabolism activator in treating ocular lesions. The research details the systematic and topical administration of this compound, exploring its effects on cellular respiration and tissue repair within the eye. It presents findings derived from experimental models, aiming to elucidate the biochemical mechanisms underlying the observed therapeutic outcomes and their implications for clinical ophthalmology.

This specialized monograph presents detailed findings on a specific pharmacological agent for ocular conditions. Its focus on biochemical mechanisms and experimental data suggests a text intended for researchers and clinicians in ophthalmology and related fields. The publication date indicates it may represent foundational research or an early exploration of this therapeutic approach.